South Korea vs Tonga: New cases tested for RR-/MDR-TB
South Korea
100.0%
in 2024
Tonga
100.0%
in 2023
South Korea rank
1st
Tonga rank
1st
New cases tested for RR-/MDR-TB over time
- South Korea
- Tonga
How they compare
South Korea currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2011 it was South Korea ahead.
South Korea ranks 1st and Tonga ranks 1st of 192 countries.
Across the 2 decades both report, South Korea averaged higher in 1 and Tonga in 1.
Head to head by decade
| Decade | South Korea | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 37.5% | 41.1% | South Korea |
| 2020s | 92.8% | 100.0% | 7.2% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South Korea or Tonga?
- South Korea, at 100.0% against 100.0% in Tonga as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between South Korea and Tonga?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Tonga?
- 12 years are reported by both, from 2011 to 2023.
- How do South Korea and Tonga rank globally for new cases tested for rr-/mdr-tb?
- South Korea ranks 1st and Tonga ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.